Paratus Diagnostics
Phil Jones is a retired urologist and active biotechnology investor based in Norman, Oklahoma with diverse business interests including medical, biotech, energy, ranching, and real estate ventures. He co-founded Norman Urology Associates and has served as president of the Norman Physician Hospital Organization and the Oklahoma State Urologic Association. He also directed the Strategic Planning Committee as a Board Member of the Norman Regional Hospital Trust Authority.
Dr. Jones served as the lead angel and board member of Selexys Pharmaceuticals, recently acquired by Novartis Pharmaceuticals, which developed a promising treatment for sickle cell anemia. He currently serves on the board of Tetherex Pharmaceuticals which is focused upon new treatments for thrombotic and inflammatory diseases.
Dr. Jones is skillfully advised in all phases of business and life by his attorney-wife Cathleen and is protected from his longhorn cattle by his ranch partners and sons, Colin of Norman, Oklahoma, and Logan of Austin, Texas.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Paratus Diagnostics
Paratus Diagnostics is a clinical laboratory and biotechnology company that is advancing the field of molecular testing and transforming point-of-care diagnostics. As a high-complexity CLIA certified lab, they provide critical and time sensitive diagnostic testing solutions to healthcare providers and patients across the United States. Developing accurate, efficient, and patient-friendly salivary tests is a core advantage. The clinical lab, located in Central Texas, serves a broad customer base with quality, timely, and cost-effective results.